An ACE in the hole: Unraveling gastrointestinal bleeding in left ventricular assist systemsAn ACE In The Hole: Unraveling Gastrointestinal Bleeding in Left Ventricular Assist Systemsretain–>

Journal of Heart and Lung Transplantation

Volumn 36, Issue 4, 2017, Pages 373-375

  Schurr, James W ^a   Stevens, Craig A ^b   Mehra, Mandeep R ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b UCSD MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ANGIOTENSIN II;

BLOOD VISCOSITY; EDITORIAL; GASTROINTESTINAL HEMORRHAGE; GASTROINTESTINAL MUCOSA; GENETIC TRANSCRIPTION; HEART LEFT VENTRICLE FAILURE; HUMAN; LEFT VENTRICULAR ASSIST DEVICE; MICROVASCULATURE; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; UPREGULATION; ARTERIOVENOUS MALFORMATION; HEART ASSIST DEVICE;

ANGIOTENSIN II; ARTERIOVENOUS MALFORMATIONS; GASTROINTESTINAL HEMORRHAGE; HEART-ASSIST DEVICES; HUMANS;

EID: 85012880985     PISSN: 10532498     EISSN: 15573117     Source Type: Journal    
DOI: 10.1016/j.healun.2017.01.1298     Document Type: Editorial

References (23)

1. 1 Wever-Pinzon, O., Selzman, C.H., Drakos, S.G., et al. Pulsatility and the risk of nonsurgical bleeding in patients supported with the continuous-flow left ventricular assist device HeartMate II. Circ Heart Fail 6 (2013), 517–526.
2. 2 Mehra, M.R., The burden of hemocompatibility with left ventricular assist systems: a complex weave. Eur Heart J, 2017 in press.
3. 3 Netuka, I., Kvasnicka, T., Kvasnicka, J., et al. Evaluation of von Willebrand factor with a fully magnetically levitated centrifugal continuous-flow left ventricular assist device in advanced heart failure. J Heart Lung Transplant 35 (2016), 860–867.
4. 4 Cochrane, J., Jackson, C., Schlepp, G., Strong, R., Gastrointestinal angiodysplasia is associated with significant gastrointestinal bleeding in patients with continuous left ventricular assist devices. Endosc Int Open 4 (2016), E371–E377.
5. 5 Loyaga-Rendon, R.Y., Hashim, T., Tallaj, J.A., et al. Octreotide in the management of recurrent gastrointestinal bleed in patients supported by continuous flow left ventricular assist devices. ASAIO J 61 (2015), 107–109.
6. 6 Ray, R., Kale, P.P., Ha, R., Banerjee, D., Treatment of left ventricular assist device-associated arteriovenous malformations with thalidomide. ASAIO J 60 (2014), 482–483.
7. 7 Gutsche, J.T., Atluri, P., Augoustides, J.G., Treatment of ventricular assist-device-associated gastrointestinal bleeding with hormonal therapy. J Cardiothorac Vasc Anesth 27 (2013), 939–943.
8. 8 Bartoli, C.R., Kang, J., Restle, D.J., et al. Inhibition of ADAMTS-13 by doxycycline reduces von Willebrand factor degradation during supraphysiological shear stress: therapeutic implications for left ventricular assist device-associated bleeding. JACC Heart Fail 3 (2015), 860–869.
9. 9 Epperla, N., Kapke, J.T., Karafin, M., Friedman, K.D., Foy, P., Effect of systemic bevacizumab in severe hereditary hemorrhagic telangiectasia associated with bleeding. Am J Hematol 91 (2016), E313–E314.
10. 10 Houston, B.A., Schneider, A.L., Vaishnav, J., et al. Angiotensin II antagonism is associated with reduced risk for gastrointestinal bleeding due to arteriovenous malformations in patients with left ventricular assist device. J Heart Lung Transplant, 2017.
11. 11 Chlench, S., Mecha Disassa, N., Hohberg, M., et al. Regulation of Foxo-1 and the angiopoietin-2/Tie2 system by shear stress. FEBS Lett 581 (2007), 673–680.
12. 12 Goettsch, W., Gryczka, C., Korff, T., et al. Flow-dependent regulation of angiopoietin-2. J Cell Physiol 214 (2008), 491–503.
13. 13 Papaioannou, T.G., Stefanadis, C., Vascular wall shear stress: basic principles and methods. Hellenic J Cardiol 46 (2005), 9–15.
14. 14 Tabit, C.E., Chen, P., Kim, G.H., et al. Elevated angiopoietin-2 level in patients with continuous-flow left ventricular assist devices leads to altered angiogenesis and is associated with higher nonsurgical bleeding. Circulation 134 (2016), 141–152.
15. 15 Sansone, R., Stanske, B., Keymel, S., et al. Macrovascular and microvascular function after implantation of left ventricular assist devices in end-stage heart failure: Role of microparticles. J Heart Lung Transplant 34 (2015), 921–932.
16. 16 Otani, A., Takagi, H., Oh, H., Koyama, S., Honda, Y., Angiotensin II induces expression of the Tie2 receptor ligand, angiopoietin-2, in bovine retinal endothelial cells. Diabetes 50 (2001), 867–875.
17. 17 David, S., Kumpers, P., Lukasz, A., Kielstein, J.T., Haller, H., Fliser, D., Circulating angiopoietin-2 in essential hypertension: relation to atherosclerosis, vascular inflammation, and treatment with olmesartan/pravastatin. Journal of hypertension 27 (2009), 1641–1647.
18. 18 Kim, H.W., Kim, J.L., Lee, H.K., Hur, D.Y., Yun, I.H., Kim, S.D., Enalapril alters expression of key growth factors in experimental diabetic retinopathy. Curr Eye Res 34 (2009), 976–987.
19. 19 Drakos, S.G., Mehra, M.R., Clinical myocardial recovery during long-term mechanical support in advanced heart failure: Insights into moving the field forward. J Heart Lung Transplant 35 (2016), 413–420.
20. 20 Pfeffer, M.A., Braunwald, E., Moye, L.A., et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators. N Engl J Med 327 (1992), 669–677.
21. 21 Cressman, A.M., Macdonald, E.M., Fernandes, K.A., et al. A population-based study of the drug interaction between clopidogrel and angiotensin converting enzyme inhibitors. Br J Clin Pharmacol 80 (2015), 662–669.
22. 22 Ahmed, A., Interaction between aspirin and angiotensin-converting enzyme inhibitors: should they be used together in older adults with heart failure?. J Am Geriatr Soc 50 (2002), 1293–1296.
23. 23 Mehra, M.R., Naka, Y., Uriel, N., et al. A fully magnetically levitated circulatory pump for advanced heart failure. N Engl J Med 376 (2017), 440–450.